| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
MRKR
Marker Therapeutics
|
Jul 09, 2026 | BUY |
Strong Buy
+799.8% avg upside
9 analysts
|
$10.00
532.93% Upside
|
· |
|
HELP
Helus Pharma
|
Jul 09, 2026 | BUY |
Strong Buy
+548.9% avg upside
12 analysts
|
$70.00
955.79% Upside
|
· |
|
DTIL
Precision BioSciences
|
Jul 09, 2026 | BUY |
Strong Buy
+158.2% avg upside
12 analysts
|
$60.00
555.01% Upside
|
· |
|
IVVD
Invivyd
|
Jul 08, 2026 | BUY |
Buy
+898.8% avg upside
8 analysts
|
$10.00
1144.22% Upside
|
+0.0% |
|
CMPS
COMPASS Pathways
|
Jul 08, 2026 | BUY |
Strong Buy
+62.5% avg upside
19 analysts
|
$70.00
414.62% Upside
|
-0.9% |
|
BEAM
Beam Therapeutics
|
Jul 07, 2026 | BUY |
Strong Buy
+42.9% avg upside
25 analysts
|
$80.00
123.29% Upside
|
-2.7% |
|
ALGS
Aligos Therapeutics
|
Jul 07, 2026 | BUY |
Buy
+581.3% avg upside
11 analysts
|
$50.00
638.47% Upside
|
· |
|
ALNY
Alnylam Pharma
|
Jul 06, 2026 | BUY |
Strong Buy
+8.5% avg upside
51 analysts
|
$470.00
50.23% Upside
|
+16.0% |
|
VYGR
Voyager Therapeutics
|
Jul 06, 2026 | BUY |
Strong Buy
+288.7% avg upside
23 analysts
|
$25.00
579.42% Upside
|
· |
|
ARWR
Arrowhead Pharmaceuticals
|
Jul 06, 2026 | BUY |
Buy
-21.5% avg upside
26 analysts
|
$100.00
19.13% Upside
|
-0.9% |
|
QURE
uniQure
|
Jun 29, 2026 | BUY |
Strong Buy
+33.9% avg upside
29 analysts
|
$80.00
79.89% Upside
|
-1.9% |
|
NRXP
NRX Pharmaceuticals
|
Jun 25, 2026 | BUY |
Strong Buy
+885.8% avg upside
5 analysts
|
$45.00
994.83% Upside
|
· |
|
ANRO
Alto Neuroscience, Inc.
|
Jun 25, 2026 | BUY |
Strong Buy
+11.1% avg upside
13 analysts
|
$50.00
80.97% Upside
|
+3.1% |
|
ATAI
Atai Beckley N.V.
|
Jun 25, 2026 | BUY |
Strong Buy
+154.1% avg upside
16 analysts
|
$25.00
369.03% Upside
|
+6.6% |
|
DRUG
Bright Minds Biosciences
|
Jun 25, 2026 | BUY |
Strong Buy
+72.8% avg upside
10 analysts
|
$145.00
85.52% Upside
|
· |
|
GOSS
Gossamer Bio
|
Jun 25, 2026 | BUY |
Hold
+4048.7% avg upside
17 analysts
|
$2.00
1042.91% Upside
|
· |
|
DFTX
Definium Therapeutics
|
Jun 23, 2026 | BUY |
Strong Buy
-10.6% avg upside
20 analysts
|
$70.00
44.45% Upside
|
+33.9% |
|
FTH
Faeth Therapeutics
|
Jun 23, 2026 | BUY |
Strong Buy
+27.2% avg upside
13 analysts
|
$60.00
84.33% Upside
|
· |
|
HRMY
Harmony Biosciences Holdings
|
Jun 23, 2026 | BUY |
Strong Buy
+22.9% avg upside
13 analysts
|
$55.00
43.86% Upside
|
+12.0% |
|
AGMB
AgomAb Therapeutics NV ADR
|
Jun 22, 2026 | BUY |
Strong Buy
+117.9% avg upside
4 analysts
|
$35.00
168.55% Upside
|
· |
|
SLN
Silence Therapeutics
|
Jun 17, 2026 | BUY |
Buy
+229.3% avg upside
10 analysts
|
$75.00
660.57% Upside
|
· |
|
GB:FARN
Faron Pharmaceuticals Oy
|
Jun 17, 2026 | BUY |
Strong Buy
+2309.7% avg upside
1 analyst
|
$1000.00
2309.72% Upside
|
· |
|
PHVS
Pharvaris
|
Jun 16, 2026 | BUY |
Strong Buy
+26.0% avg upside
14 analysts
|
$60.00
66.81% Upside
|
+15.9% |
|
SGMOQ
Sangamo Therapeutics
|
Jun 09, 2026 | HOLD |
Buy
+13214.5% avg upside
16 analysts
|
— | · |
|
ALT
Altimmune
|
Jun 03, 2026 | BUY |
Strong Buy
+761.0% avg upside
20 analysts
|
$20.00
541.11% Upside
|
· |
|
IMCR
Immunocore Holdings
|
Jun 03, 2026 | BUY |
Strong Buy
+93.8% avg upside
22 analysts
|
$100.00
202.35% Upside
|
+16.5% |
|
VIR
Vir Biotechnology
|
Jun 03, 2026 | BUY |
Strong Buy
+152.8% avg upside
16 analysts
|
$20.00
93.50% Upside
|
+18.9% |
|
ASMB
Assembly Biosciences
|
Jun 03, 2026 | BUY |
Strong Buy
+21.1% avg upside
10 analysts
|
$50.00
79.46% Upside
|
· |
|
ONCY
Oncolytics Biotech
|
May 29, 2026 | BUY |
Strong Buy
+696.5% avg upside
12 analysts
|
$10.00
986.87% Upside
|
-18.2% |
|
GHRS
GH Research
|
May 19, 2026 | BUY |
Strong Buy
+35.4% avg upside
11 analysts
|
$65.00
139.02% Upside
|
+22.4% |
|
MIST
Milestone Pharmaceuticals
|
Apr 02, 2025 | BUY |
Strong Buy
+539.0% avg upside
7 analysts
|
$10.00
663.41% Upside
|
+71.9% |
|
QTTB
Q32 Bio
|
May 15, 2023 | BUY |
Buy
+310.2% avg upside
24 analysts
|
$360.00
2759.47% Upside
|
+60.1% |
|
BNTC
Benitec Biopharma
|
Feb 10, 2023 | HOLD |
Strong Buy
+97.1% avg upside
13 analysts
|
— | -37.9% |
|
TSE:PHRM
PharmaTher Holdings Ltd
|
Feb 10, 2023 | HOLD |
Hold
1 analyst
|
— | · |
|
GB:AGY
Allergy Therapeutics
|
Nov 02, 2022 | BUY |
Strong Buy
+31006.1% avg upside
2 analysts
|
$46.03
586.97% Upside
|
· |
|
DE:EVT
Evotec
|
Mar 27, 2020 | BUY |
Strong Buy
+234.7% avg upside
8 analysts
|
$33.00
561.22% Upside
|
· |
|
SUPN
Supernus Pharmaceuticals
|
Nov 08, 2019 | HOLD |
Strong Buy
+10.8% avg upside
7 analysts
|
$24.00
50.77% Downside
|
+8.6% |
|
ENTA
Enanta Pharmaceuticals
|
Sep 18, 2019 | BUY |
Buy
+130.1% avg upside
17 analysts
|
$130.00
812.28% Upside
|
-34.7% |
|
PRGO
Perrigo Company
|
Nov 13, 2018 | HOLD |
Buy
+552.2% avg upside
20 analysts
|
$72.00
591.71% Upside
|
-24.8% |
|
IRWD
Ironwood Pharma
|
Apr 19, 2018 | BUY |
Hold
+153.8% avg upside
23 analysts
|
$25.00
435.37% Upside
|
-23.6% |
|
INVA
Innoviva
|
Apr 19, 2018 | BUY |
Strong Buy
+28.7% avg upside
12 analysts
|
$22.00
0.99% Downside
|
-19.3% |
|
KMB
Kimberly Clark
|
Dec 23, 2014 | BUY |
Buy
+14.2% avg upside
30 analysts
|
$125.00
13.75% Upside
|
+11.2% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.